Biotech · Private company
DEKK-TEC, Inc.
Track this companyFree. Adds DEKK-TEC, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- 4-Demethyl-4-cholestryloxycarbonylpenclomedinePhase 2 · Primary Brain TumorsClinicalTrials.gov · fetched Nov 12, 2026
- DM-CHOC-PENPhase 2 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- 4-Demethyl-4-cholesteryloxycarbonylpenclomedinePhase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- DM-CHOC-PEN for Brain Tumors in AYA SubjectsPHASE2 · COMPLETED · started Jan 1, 2019ClinicalTrials.gov NCT03668847 · fetched Nov 12, 2026
- DM-CHOC-PEN Plus Radiation for Brain TumorsPHASE1 · COMPLETED · started Feb 5, 2016ClinicalTrials.gov NCT03371004 · fetched Nov 12, 2026
- Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain TumorsPHASE2 · COMPLETED · started Sep 1, 2013ClinicalTrials.gov NCT02038218 · fetched Nov 12, 2026
- Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced CancerPHASE1 · COMPLETED · started Sep 1, 2010ClinicalTrials.gov NCT01048008 · fetched Nov 12, 2026
- Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer"PHASE1 · COMPLETED · started Sep 1, 2010ClinicalTrials.gov NCT01976910 · fetched Nov 12, 2026
- A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced CancersNO_LONGER_AVAILABLEClinicalTrials.gov NCT02889445 · fetched Nov 12, 2026